Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Very early researchEnded earlyNCT01276613
What this trial is testing

Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT03080974
What this trial is testing

Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
University of Louisville 10
Testing effectiveness (Phase 2)Looking for participantsNCT07488676
What this trial is testing

ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 150
Not applicableEnded earlyNCT06341725
What this trial is testing

EUS Role in Non-metastatic Pancreatic Adenocarcinoma Lymph Nodes Staging

Who this might be right for
Pancreatic AdenocarcinomaLymph Node Metastasis
Paolo Giorgio Arcidiacono, MD 2
Testing effectiveness (Phase 2)Ended earlyNCT03376659
What this trial is testing

Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Colorectal CancerColorectal AdenocarcinomaPancreatic Adenocarcinoma+1 more
Georgetown University 8
Testing effectiveness (Phase 2)Study completedNCT01693523
What this trial is testing

Minocycline Study in Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 80
Testing effectiveness (Phase 2)Looking for participantsNCT06261359
What this trial is testing

CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Qilu Pharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT02487836
What this trial is testing

Trial Evaluating the Efficacy of Laying a Biliary Stent for Producing a Heavy Chemotherapy in Unresectable Pancreatic Adenocarcinomas

Who this might be right for
Adenocarcinoma of Head of Pancreas
Institut Paoli-Calmettes 6
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Study completedNCT00102700
What this trial is testing

ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdenocarcinoma
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 66
Not applicableStudy completedNCT07182136
What this trial is testing

The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy

Who this might be right for
Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy
Wei-Hsun Lu 200
Testing effectiveness (Phase 2)Study completedNCT00003677
What this trial is testing

Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 9
Early research (Phase 1)Study completedNCT00547612
What this trial is testing

Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
National Institutes of Health Clinical Center (CC) 33
Not applicableUnknownNCT04164602
What this trial is testing

The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly

Who this might be right for
Diabetes MellitusDiabetesDiabetes Mellitus, Type 2+5 more
University of Pecs 2,522
Testing effectiveness (Phase 2)Study completedNCT04731467
What this trial is testing

CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerPancreatic Cancer+4 more
Famewave Ltd. 79
Large-scale testing (Phase 3)Active Not RecruitingNCT03899636
What this trial is testing

A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer

Who this might be right for
Stage III Pancreatic Cancer
Angiodynamics, Inc. 528
Not applicableUnknownNCT00079365
What this trial is testing

Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
University of South Florida
Not applicableEnded earlyNCT04476537
What this trial is testing

RNA Precision Oncology in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Columbia University 16
Not applicableLooking for participantsNCT07587866
What this trial is testing

Panuri Performance Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Urteste S.A 1,100
Next Page